For research use only. Not for therapeutic Use.
Zelicapavir（Cat No.:I042649）is an investigational antiviral peptide inhibitor designed for the treatment of chronic hepatitis B virus (HBV) infection. By targeting the HBV core protein, Zelicapavir disrupts the viral lifecycle, preventing the formation of the viral capsid, a crucial step in the replication process. This peptide demonstrates potent antiviral activity against HBV and holds promise for patients who have developed resistance to conventional therapies. Zelicapavir is currently undergoing clinical trials to evaluate its safety, efficacy, and potential to improve long-term treatment outcomes for chronic HBV infection.
| CAS Number | 2070852-76-3 |
| Synonyms | (3S)-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
| Molecular Formula | C27H22F3N7O3 |
| Purity | ≥95% |
| IUPAC Name | (3S)-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
| InChI | InChI=1S/C27H22F3N7O3/c28-27(29,30)17-14-20(37-10-12-39-13-11-37)22(31-15-17)25-35-36-26(40-25)34-23-24(38)32-19-9-5-4-8-18(19)21(33-23)16-6-2-1-3-7-16/h1-9,14-15,23H,10-13H2,(H,32,38)(H,34,36)/t23-/m1/s1 |
| InChIKey | VGGNPZNYTJXPEW-HSZRJFAPSA-N |
| SMILES | C1COCCN1C2=C(N=CC(=C2)C(F)(F)F)C3=NN=C(O3)N[C@@H]4C(=O)NC5=CC=CC=C5C(=N4)C6=CC=CC=C6 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
